Skip to main content

Commercial Medical Policy Update for April 17, 2024

Medical GuidelinesReason for Update
Biochemical Markers of Alzheimer Disease and Dementia AHS – G2048 (PDF)

CPT codes 0443U and 0445U added to Billing/Coding section, effective 4/1/24.

Biomarker Testing for Autoimmune Rheumatic Disease AHS – G2022 (PDF)

Updated Billing/Coding section to add 0446U and 0447U, effective 4/1/2024.

Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases AHS – G2123 (PDF)

CPT code 0443U added to the Billing/Coding Section, effective 4/1/24. 

Genetic Markers for Assessing Risk of Cardiovascular Disease AHS – M2180 (PDF)

Codes 0439U and 0440U added to Billing/Coding section, effective 4/1/24.

Laboratory Procedures Medical Policy AHS - R2162 (PDF)

Code 0449U added to Billing/Coding section, effective 4/1/24.

Pathogen Panel Testing AHS – G2149 (PDF)

Codes 0441U and 0442U added to Billing/Coding section, effective 4/1/24.

Perirectal Spacer Use During Radiotherapy for Prostate Cancer (PDF)

Off cycle review to add not medically necessary statement for proton beam therapy. Under “when not covered” section added: “Transperineal placement of a biodegradable, perirectal spacer (ie SpaceOAR) is considered not medically necessary in individuals undergoing proton beam therapy for treatment of prostate cancer.” References added. Medical Director review 1/2024. Notification given 2/6/24 for effective date 4/17/24.